Carboxy Therapy Market Size Worth $108.49 Million By 2032 | CAGR: 11.7%

Carboxy Therapy Market Size Worth $108.49 Million By 2032 | CAGR: 11.7%


The global carboxy therapy market size is expected to reach USD 108.49 million by 2032, according to a new study by Polaris Market Research. The report “Carboxy Therapy Market Share, Size, Trends, Industry Analysis Report, By Product Type (Table Top, Portable); By End-use (Hospitals, Aesthetic Clinics, Medspa); And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising awareness of the non-invasive procedures are expected to drive the demand for such procedures across the globe. One of the primary applications of carboxy therapy is in the treatment of cellulite. The injection of carbon dioxide helps to improve blood circulation, promote lymphatic drainage, and stimulate collagen production, which can lead to a reduction in the appearance of cellulite. This makes carboxy therapy an attractive option for individuals seeking to address this common aesthetic concern.

In addition to cellulite, carboxy therapy is also used to target other cosmetic issues such as wrinkles. The introduction of carbon dioxide gas stimulates the production of collagen and elastin, which are essential components for maintaining skin elasticity and reducing the appearance of wrinkles. By promoting skin rejuvenation and tightening, carboxy therapy can help individuals achieve a more youthful and refreshed appearance. Under-eye dark circles, another common concern, can also be treated with carboxy therapy. The increased blood flow and oxygenation resulting from the injection of carbon dioxide can improve the appearance of dark circles, reducing their visibility and brightening the under-eye area.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/carboxy-therapy-market/request-for-sample

The growing demand for non-surgical and minimally invasive cosmetic procedures, particularly among the aging population, is a significant driver of the carboxy therapy market. As individuals seek effective solutions to address signs of aging and improve their appearance, non-surgical options like carboxy therapy offer attractive benefits such as minimal downtime, fewer risks, and natural-looking results.

Furthermore, the increasing awareness of the advantages of carboxy therapy for improving skin texture contributes to market growth. As more people become aware of the potential benefits of this procedure, including its ability to stimulate collagen production, improve blood circulation, and enhance skin tone and texture, the demand for carboxy therapy increases.

The International Society of Aesthetic Plastic Surgery's 2021 report indicates a notable increase in the number of face and head surgical procedures worldwide. These procedures experienced a growth rate of approximately 14.8% from the previous year, reaching a total of 5,211,933 procedures globally. Additionally, face and head surgical procedures account for approximately 40.59% of the total number of surgical procedures performed. As a result, the carboxy therapy market is poised to experience substantial growth in the coming years.

Carboxy Therapy Market Report Highlights

  • Table top segment accounted for highest market share in 2022, due to high availability of such devices in the aesthetic clinics
  • Aesthetic clinics segment held the maximum market revenue share in 2022, due to growing preference of aesthetic clinics & its cost effectiveness
  • North America region dominated the global market, owing to rise in geriatrics and rise in preference of minimally invasive procedures
  • The global key market players include DTA Medical, Mezopharma, MBE Medical Divisons, Alvi Prague, Kastner-Praxisbedarf, Beijing Jontelaser, Cosmopro, Carbossiterapia Italiana, and MEDAiON Plasma.

Polaris Market Research has segmented the carboxy therapy market report based on product type, end-use, and region:

Carboxy Therapy, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Table Top
  • Portable

Carboxy Therapy, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Aesthetic Clinics
  • Medspa

Carboxy Therapy, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Carboxy Therapy Market Report Scope

Report Attributes

Details

Market size value in 2023

USD 39.92 million

Revenue forecast in 2032

USD 108.49 million

CAGR

11.7% from 2023 – 2032

Base year

2022

Historical data

2021 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD million and CAGR from 2023 to 2032

Segments covered

By Product Type, By End Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

DTA Medical, Mezopharma, MBE Medical Divisons, Alvi Prague, Kastner-Praxisbedarf, Beijing Jontelaser, Cosmopro, Carbossiterapia Italiana, and MEDAiON Plasma

For Specific Research Requirements

Request for Customized Report

License and Pricing

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing